The present review discusses, for the first time, the impact of anthranilic acid (AA), a putative endogenous agonist of the G-protein coupled receptor (GPR109A), on myelin integrity and, consequently, on the prevention and treatment of cognitive impairment. This evidence concerns the gene HCAR2 and Cognitive impairment.